Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This work will focus on the anti-inflammatory and antioxidant pathways in lung diseases by measuring HO-1 in induced sputum and CO in exhaled air in cases of four respiratory diseases, asthma, chronic obstructive pulmonary disease (COPD), occupational lung diseases (OLD) and interstitial lung disease (ILD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples

NCT01631162

Asthma Chronic Obstructive Lung Disease

UNKNOWN NA

Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non Exacerbators

NCT01745419

Pulmonary Disease, Chronic Obstructive

COMPLETED

Respiratory Pathogens of Patients With Asthma and COPD Exacerbations

NCT02866357

COPD

COMPLETED

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

NCT00512967

Interstitial Lung Diseases Sarcoidosis Idiopathic Pulmonary Fibrosis +1 more

COMPLETED

Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)

NCT00655694

Pulmonary Disease, Chronic Obstructive

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female
* Ages \>/= 18 years
* Diagnosed with one or more lung diseases
* Referred for sputum induction to the Pulmonary Laboratory in the Tel-Aviv Sourasky Medical Center

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes